covaxin

Covaxin: WHO to consider emergency listing at today’s meeting

The World Health Organization (WHO) will meet on Tuesday to consider granting Covaxin, India's indigenous coronavirus vaccine, emergency use approval…

3 years ago

Covaxin development has demonstrated that India is more than a world pharmacy: ICMR chief

The ICMR collaborated with Bharat Biotech to produce India's first indigenous COVID-19 vaccine. What are the key takeaways from this…

3 years ago

The United States will allow travellers who received Covid vaccines in mixed doses to enter the country

Key Highlights While the CDC in the United States does not allow mixed vaccines in primary series, it is fairly…

3 years ago

Bharat Biotech’s kids’ vaccine is good news. But why is its vaccine for adults yet to get WHO clearance?

Bharat Biotech is on the verge of becoming the second Indian vaccine manufacturer to gain emergency use permission for a…

3 years ago

Covaxin Has Been Approved For Children Aged 2 to 18

The Drugs and Comptroller General of India (DCGI) is said to have authorised the administration of Bharat Biotech's Covaxin to…

3 years ago

Covaxin trial on children results suggest same effect as on adults: Experts

As India's largest COVID-19 vaccination drive begins, an AIIMS professor claims that the latest trials show that the safety and…

3 years ago

Healthcare workers face stigma after Covid outbreak: ICMR study

The Indian Council of Medical Research (ICMR) conducted a study on healthcare workers (HCWs) from 11 cities in the country,…

3 years ago

Nasal vaccine a gamechanger, may protect from Covid infection; claims Dr Sanjay Rai

“We are going to start trial for nasal vaccine very soon and I believe it might be a game changer…

3 years ago

Only 1 in 11 people receive Covaxin as Bharat Biotech fails to ramp up production

Due to a shortage in the market, only one out of every eleven Indians has received the indigenous vaccine, Covaxin,…

3 years ago

Covaxin Delayed Emergency Approval from WHO until 5 October

Approvals to COVID-19 Covaxin, developed by the Bharat Biotech based in Hyderabad, is expected to be delayed until October 5,…

3 years ago